Cargando…
T cell recognition of Mycobacterium tuberculosis peptides presented by HLA-E derived from infected human cells
HLA-E is a non-conventional MHC Class I molecule that has been recently demonstrated to present pathogen-derived ligands, resulting in the TCR-dependent activation of αβ CD8(+) T cells. The goal of this study was to characterize the ligandome displayed by HLA-E following infection with Mycobacterium...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703486/ https://www.ncbi.nlm.nih.gov/pubmed/29176828 http://dx.doi.org/10.1371/journal.pone.0188288 |
Sumario: | HLA-E is a non-conventional MHC Class I molecule that has been recently demonstrated to present pathogen-derived ligands, resulting in the TCR-dependent activation of αβ CD8(+) T cells. The goal of this study was to characterize the ligandome displayed by HLA-E following infection with Mycobacterium tuberculosis (Mtb) using an in-depth mass spectrometry approach. Here we identified 28 Mtb ligands derived from 13 different source proteins, including the Esx family of proteins. When tested for activity with CD8(+) T cells isolated from sixteen donors, nine of the ligands elicited an IFN-γ response from at least one donor, with fourteen of 16 donors responding to the Rv0634A(19-29) peptide. Further evaluation of this immunodominant peptide response confirmed HLA-E restriction and the presence of Rv0634A(19-29)-reactive CD8(+) T cells in the peripheral blood of human donors. The identification of an Mtb HLA-E ligand that is commonly recognized may provide a target for a non-traditional vaccine strategy. |
---|